Dr. Downs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 Ray C Hunt Dr
Charlottesville, VA 22903Phone+1 434-924-2224Fax+1 434-244-9481
Summary
- Dr. Downs is certified by the American Board of Urology. He specializes in the surgical treatment of urologic cancers and treats all forms of urologic cancers including bladder cancer, prostate cancer, kidney cancer, testis cancer and penile cancer. He has a special interest in the treatment of bladder cancer, where he performs robotic cystectomy (da Vinci robotic system), along with complex urinary reconstruction to make a new internalized bladder (orthotopic neobladder). Dr. Downs’ clinical care philosophy is to provide compassionate, cutting-edge urologic cancer care to his patients.
Research Interests
Dr. Downs has a joint appointment with the UW Carbone Cancer Center, and his clinical research emphasizes developing new therapies for genitourinary cancers.
Research Focus
Chemoprevention – Bladder cancer, prostate cancer
Screening Programs – Bladder cancer screening for high-risk subjects
Outcomes Research – Patient outcomes of treatments for non-muscle invasive (superficial) bladder cancer and radical cystectomy
Translational Research – Discovery of molecular and urinary biomarkers (bladder cancer)
Quality of Life Outcomes – Bladder cancer, prostate cancer
Education & Training
- University of California (San Francisco)Fellowship, Minimally Invasive Urologic Surgery, 2001 - 2003
- Brigham and Women's Hospital/Harvard Medical SchoolResidency, Urology, 1995 - 2001
- Brigham and Women's HospitalResidency, Surgery, 1993 - 1995
- University of California San Diego School of MedicineClass of 1993
Certifications & Licensure
- CA State Medical License 2001 - Present
- VA State Medical License 2021 - 2026
- WI State Medical License 2010 - 2023
- MA State Medical License 1999 - 2008
- American Board of Urology Urology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer Start of enrollment: 2008 Jul 02
- Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance Start of enrollment: 2014 May 08
- Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery Start of enrollment: 2014 Oct 01
Publications & Presentations
PubMed
- 3 citationsClinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non-Muscle-Invasive Bladder Cancer: Retrospective Cohort...Joseph M. Plasek, John Weissert, Tracy M. Downs, Kyle A. Richards, Kourosh Ravvaz
JMIR Cancer. 2021-06-22 - 8 citationsDevelopment and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approachCheryl T. Lee, Nihal Mohamed, Sailaja Pisipati, Qainat N. Shah, Piyush K. Agarwal
BMC Health Services Research. 2020-07-24 - 160 citationsNCCN Guidelines Insights: Bladder Cancer, Version 5.2018Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian
Journal of the National Comprehensive Cancer Network. 2018-09-01
Press Mentions
- UVA Health Hires Chief Diversity & Community Engagement OfficersApril 12th, 2021
- Better Models Needed for Predicting Bladder Ca RecurrenceOctober 11th, 2017
- Q&A: Brian Gittens' Diversity MissionApril 10th, 2017
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: